• Pocket Analyst Logo
  • Search
  • Chat
  • News
  • Discover
  • Portfolio
  • Contact
  • Sign In
Conversations
  • Sign up to save conversations
    flag
    ASX200
    -0.21%
    SIG.AX logo
    Sigma Healthcare Limited
    SIG.AXflag
    Latest News
    negative

    Sigma Healthcare reported a small loss of AU$0.009 per share for the full year 2025, compared to a previous profit of AU$0.004 per share.

    Last generated Jun 20, 2025

    Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia. It operates approximately 1,200 branded and independent pharmacy stores under the Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave brands. The company also provides hospital pharmacy wholesale services; dose administration aid services to the aged care sector, community pharmacy sector, and in the home; technology solutions and data analytics; and product development and support for a range of private and exclusive label products, as well as supplies medical consumables and devices to a broad range of customers, including pharmacy aged care facilities, hospitals, and clinics. In addition, it offers contract logistics services to pharmaceutical manufacturers and other supplier partners. Sigma Healthcare Limited was founded in 1912 and is headquartered in Rowville, Australia.

    Market Cap.$36.07B
    SectorHealthcare
    IndustryMedical - Distribution
    PE Ratio-365.17
    Profit Margin-0.29%
    Beta0.15
    Dividend Yield0.16%
    Consensus RatingNeutral
    Dividends
    Dividend Amount (TTM)0.01
    Dividend Yield (TTM)0.16%
    Payout Ratio-1.14%
    Valuation
    Price to Earnings (PE) Ratio-357.21
    Price to Sales (PS) Ratio 7.45
    Price to Book (PB) Ratio 5.90
    Price to Free Cash Flow (PFCF) Ratio -111.49
    Price to Earnings Growth (PEG) Ratio 3.42
    Profitability
    Profit Margin-0.29%
    Gross Margin5.55%
    Return on Equity-1.62%
    Return on Assets-0.76%
    Finances
    Debt to Equity Ratio0.16
    Current Ratio1.59
    Cash Ratio0.02
    Growth
    Earnings Per Share Growth (5Y)-120.56%
    Revenue Growth (5Y)43.92%